central nervous system

Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024[...]

By sjmartinez • August 8, 2024

Low-grade B-cell lymphoma of the central nervous system with plasmacytic differentiation and amyloid deposition

Lopez G, Han K, Magaki SD, Song SX, Salamon N, Kahlon KS, Keselman I, Bari AA, Vinters HV. Low-grade B-cell lymphoma of the central nervous[...]

By sjmartinez • August 3, 2023